Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

BACKGROUND: Glucocorticoid treatment remains the cornerstone of therapy for immune checkpoint inhibitor (ICI) myocarditis, but data supporting the use of additional immunotherapy for steroid refractory cases remains limited. We investigate the safety and efficacy of infliximab in patients with ICI m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiooncology
Autori principali: Zhang, Robert S., Padegimas, Allison, Murphy, Kathleen M., Evans, Peter T., Peters, Carli J., Domenico, Christopher M., Vidula, Mahesh K., Mather, Paul J., Cevasco, Marisa, Cohen, Roger B., Carver, Joseph R., O’Quinn, Rupal P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008661/
https://ncbi.nlm.nih.gov/pubmed/33785062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40959-021-00095-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi